Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Verschueren

Showing results (111-120 of 155) with videos related to

Pageof 16
Sort By:
Therapeutic Advances in Musculoskeletal Disease|March 1, 2024
To flare or not to flare: patients' and rheumatologists' perceptions on the on-flare retreatment strategy of rituximab in rheumatoid arthritisDelphine Bertrand, Anke Deprez, Michaël Doumen, et al.
Musculoskeletal Care|May 2, 2024
Patients' and rheumatologists' perceptions on dose reduction of rituximab in rheumatoid arthritisDelphine Bertrand, Anke Deprez, Michaël Doumen, et al.
Musculoskeletal Care|November 15, 2011
The association of illness perceptions with physical and mental health in systemic sclerosis patients: an exploratory studySeher Arat, Patrick Verschueren, Ellen De Langhe, et al.
Rheumatology (Oxford, England)|January 25, 2011
Antibodies to heterogeneous nuclear ribonucleoprotein H1 are directed to RNA recognition motif 3Katrijn Op de Beéck, Karolien Van den Bergh, René Westhovens, et al.
Vaccines|October 26, 2024
Did We Overreact? Insights on COVID-19 Disease and Vaccination in a Large Cohort of Immune-Mediated Inflammatory Disease Patients during Sequential Phases of the Pandemic (The BELCOMID Study)Jeroen Geldof, Marie Truyens, João Sabino, et al.
Frontiers in Immunology|March 20, 2023
SARS-CoV-2 infection and COVID19 vaccination across eight immune-mediated inflammatory disorders: A prospective, real-life Belgian cohort study - the BELCOMID studyJeroen Geldof, Marie Truyens, João Sabino, et al.
Annals of the Rheumatic Diseases|July 23, 2024
New WHO ACPA standard enables standardisation among anti-CCP2 assays, but not other ACPA assays using different antigensLieve Van Hoovels, Liesbeth E Bakker-Jonges, Dina Vara, et al.
Arthritis Care & Research|September 29, 2019
First Validation of the Full PROMIS Pain Interference and Pain Behavior Item Banks in Patients With Rheumatoid ArthritisMartine H P Crins, Caroline B Terwee, Rene Westhovens, et al.
Annals of the Rheumatic Diseases|December 16, 2022
Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritisLotte van Ouwerkerk, Maarten Boers, Paul Emery, et al.
Infectious Diseases (London, England)|June 7, 2024
Effects of implementing a vaccination tool in the electronic medical record on vaccination coverage of patients with immune-mediated inflammatory diseases: a prospective cohort studyLiselotte Fierens, Sofie Coenen, Johan Joly, et al.
Pageof 16

Showing results (111-120 of 155) with videos related to

Sort By:
Pageof 16
Therapeutic Advances in Musculoskeletal Disease|March 1, 2024
To flare or not to flare: patients' and rheumatologists' perceptions on the on-flare retreatment strategy of rituximab in rheumatoid arthritisDelphine Bertrand, Anke Deprez, Michaël Doumen, et al.
Musculoskeletal Care|May 2, 2024
Patients' and rheumatologists' perceptions on dose reduction of rituximab in rheumatoid arthritisDelphine Bertrand, Anke Deprez, Michaël Doumen, et al.
Musculoskeletal Care|November 15, 2011
The association of illness perceptions with physical and mental health in systemic sclerosis patients: an exploratory studySeher Arat, Patrick Verschueren, Ellen De Langhe, et al.
Rheumatology (Oxford, England)|January 25, 2011
Antibodies to heterogeneous nuclear ribonucleoprotein H1 are directed to RNA recognition motif 3Katrijn Op de Beéck, Karolien Van den Bergh, René Westhovens, et al.
Vaccines|October 26, 2024
Did We Overreact? Insights on COVID-19 Disease and Vaccination in a Large Cohort of Immune-Mediated Inflammatory Disease Patients during Sequential Phases of the Pandemic (The BELCOMID Study)Jeroen Geldof, Marie Truyens, João Sabino, et al.
Frontiers in Immunology|March 20, 2023
SARS-CoV-2 infection and COVID19 vaccination across eight immune-mediated inflammatory disorders: A prospective, real-life Belgian cohort study - the BELCOMID studyJeroen Geldof, Marie Truyens, João Sabino, et al.
Annals of the Rheumatic Diseases|July 23, 2024
New WHO ACPA standard enables standardisation among anti-CCP2 assays, but not other ACPA assays using different antigensLieve Van Hoovels, Liesbeth E Bakker-Jonges, Dina Vara, et al.
Arthritis Care & Research|September 29, 2019
First Validation of the Full PROMIS Pain Interference and Pain Behavior Item Banks in Patients With Rheumatoid ArthritisMartine H P Crins, Caroline B Terwee, Rene Westhovens, et al.
Annals of the Rheumatic Diseases|December 16, 2022
Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritisLotte van Ouwerkerk, Maarten Boers, Paul Emery, et al.
Infectious Diseases (London, England)|June 7, 2024
Effects of implementing a vaccination tool in the electronic medical record on vaccination coverage of patients with immune-mediated inflammatory diseases: a prospective cohort studyLiselotte Fierens, Sofie Coenen, Johan Joly, et al.
Pageof 16